News
TEM
68.11
-0.82%
-0.56
Hims & Hers Scales Technology-Driven Care as Profitability Evolves
NASDAQ · 7h ago
Tempus AI: Plenty Of Growth Catalysts Ahead, Grab It While It's Down
Seeking Alpha · 9h ago
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up
NASDAQ · 10h ago
3 MedTech Stocks Poised to Gain in 2026 From the AI Boom
NASDAQ · 11h ago
Tempus AI Is Maintained at Neutral by JP Morgan
Dow Jones · 1d ago
Tempus AI Price Target Cut to $80.00/Share From $85.00 by JP Morgan
Dow Jones · 1d ago
JP Morgan Maintains Neutral on Tempus AI, Lowers Price Target to $80
Benzinga · 1d ago
Tempus AI Near $75 Target? Valuation, Upside and Risks
NASDAQ · 1d ago
Tempus AI price target lowered to $80 from $90 at BofA
TipRanks · 1d ago
Tempus AI price target lowered to $80 from $85 at JPMorgan
TipRanks · 1d ago
Bank of America Securities Sticks to Their Hold Rating for Tempus AI, Inc. Class A (TEM)
TipRanks · 1d ago
TEMPUS AI INC <TEM.O>: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $80 FROM $90
Reuters · 1d ago
Cathie Wood tilts toward Robinhood, Bitcoin ETFs, trims Tesla, Iridium
Seeking Alpha · 1d ago
Weekly Report: what happened at TEM last week (1208-1212)?
Weekly Report · 1d ago
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 1d ago
Tempus AI CFO James William Rogers Reports Sale of Common Shares
Reuters · 4d ago
Tempus AI's Strategic Push to Expand Beyond Oncology
NASDAQ · 5d ago
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition?
NASDAQ · 6d ago
Director Cashes In on Tempus AI Stock!
TipRanks · 6d ago
Is Tempus AI Still Attractive After Its 121.5% Surge and AI Healthcare Momentum in 2025?
Simply Wall St · 12/10 00:39
More
Webull provides a variety of real-time TEM stock news. You can receive the latest news about Tempus AI through multiple platforms. This information may help you make smarter investment decisions.
About TEM
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.